An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss

Journal of Neuroimmunology

Volumn 201-202, Issue C, 2008, Pages 200-211

  Hampton, David W ^a   Anderson, Jane ^a   Pryce, Gareth ^b   Irvine, Karen Amanda ^d   Giovannoni, Gavin ^b   Fawcett, James W ^a   Compston, Alastair ^a   Franklin, Robin J M ^a,c   Baker, David ^b   Chandran, Siddharthan ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Axon; Experimental autoimmune encephalomyelitis; Gliosis; Multiple sclerosis; Remyelination

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; GLIOSIS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REMYELINIZATION;

ANIMALS; ANTIGENS; AXONS; DISEASE MODELS, ANIMAL; GLIOSIS; MICE; MICE, BIOZZI; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEURONS; PROTEOGLYCANS; SPINAL CORD;

EID: 51649118004     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.05.034     Document Type: Article

References (56)

1. Ahmed Z., Doward A.I., Pryce G., et al. A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis: inflammation versus degeneration. Am. J. Pathol. 161 (2002) 1577-1586
2. Alvarez F.J., Villalba R.M., Zerda R., et al. Vesicular glutamate transporters in the spinal cord, with special reference to sensory primary afferent synapses. J. Comp. Neurol. 472 (2004) 257-280
3. Amor S., Smith P.A., Hart B., et al. Biozzi mice: of mice and human neurological diseases. J. Neuroimmunol. 165 (2005) 1-10
4. Arnett H.A., Mason J., Marino M., et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4 (2001) 1116-1122
5. Arnett H.A., Fancy S.P., Alberta J.A., et al. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306 (2004) 2111-2115
6. Baker D., O'Neill J.K., Gschmeissner S.E., et al. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 28 (1990) 261-270
7. Baker D., Pryce G., Croxford J.L., et al. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404 (2000) 84-87
8. Bannerman P., Hahn A., Soulika A., et al. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia 55 (2007) 57-64
9. Bieber A.J., Kerr S., and Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann. Neurol. 53 (2003) 680-684
10. Blakemore W.F., Gilson J.M., and Crang A.J. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp. Neurol. 184 (2003) 955-963
11. Cifelli A., Arridge M., Jezzard P., et al. Thalamic neurodegeneration in multiple sclerosis. Ann. Neurol. 52 (2002) 650-653
12. Coles A.J., Wing M.G., Molyneux P., et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann. Neurol. 46 (1999) 296-304
13. Compston A., and Coles A. Multiple sclerosis. Lancet 359 (2002) 1221-1231
14. Costa O., Divoux D., Ischenko A., et al. Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG(35-55)peptide in C57BL6/J strain of mice. J. Autoimmun. 20 (2003) 51-61
15. DeLuca G.C., Ebers G.C., and Esiri M.M. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 127 (2004) 1009-1018
16. Foote A.K., and Blakemore W.F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128 (2005) 528-539
17. Franklin R.J.M., Hinks G.L., Woodruff R.H., et al. What roles do growth factors play in CNS remyelination?. Prog. Brain Res. 132 (2001) 185-193
18. Franklin R.J.M. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 3 (2002) 705-714
19. Frohman E.M., Racke M.K., and Raine C.S. Multiple sclerosis - the plaque and its pathogenesis. N. Engl. J. Med. 354 (2006) 942-955
20. Gilgun-Sherki Y., Panet H., Holdengreber V., et al. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis. Neurosci. Res. 47 (2003) 201-207
21. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
22. Hampton D.W., Rhodes K.E., Zhao C., et al. The responses of oligodendrocyte precursor cells, astrocytes and microglia to a cortical stab injury, in the brain. Neuroscience 127 (2004) 813-820
23. Hampton D.W., Steeves J.D., Fawcett J.W., et al. Spinally upregulated noggin suppresses axonal and dendritic plasticity following dorsal rhizotomy. Exp. Neurol. 204 (2007) 366-379
24. Hoffman G.E., Le W.W., Murphy A.Z., et al. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp. Neurol. 171 (2001) 272-284
25. Kerschensteiner M., Stadelmann C., Buddeberg B.S., et al. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am. J. Pathol. 164 (2004) 1455-1469
26. Kerschensteiner M., Bareyre F.M., Buddeberg B.S., et al. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J. Exp. Med. 200 (2004) 1027-1038
27. Kornek B., Storch M.K., Weissert R., et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157 (2000) 267-276
28. Kotter M.R., Setzu A., Sim F.J., et al. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35 (2001) 204-212
29. Kuhlmann T., Lingfeld G., Bitsch A., et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 (2002) 2202-2212
30. Lee S.C., Moore G.R., Golenwsky G., et al. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropathol. Exp. Neurol. 49 (1990) 122-136
31. Lucchinetti C., Brück W., Parisi J., et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122 (1999) 2279-2295
32. MacDermid V.E., McPhail L.T., Tsang B., et al. A soluble Nogo receptor differentially affects plasticity of spinally projecting axons. Eur. J. Neurosci. 20 (2004) 2567-2579
33. Mason J.L., Suzuki K., Chaplin D.D., et al. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21 (2001) 7046-7052
34. Pagany M., Jagodic M., Bourquin C., et al. Genetic variation in myelin oligodendrocyte glycoprotein expression and susceptibility to experimental autoimmune encephalomyelitis. J. Neuroimmunol. 139 (2003) 1-8
35. Papadopoulos D., Pham-Dinh D., and Reynolds R. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp. Neurol. 197 (2006) 373-385
36. Patani R., Balaratnam M., Vora A., et al. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 33 (2007) 277-287
37. Patrikios P., Stadelmann C., Kutzelnigg A., et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129 (2006) 3165-3172
38. Penderis J., Shields S.A., and Franklin R.J.M. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 126 (2003) 1382-1391
39. Peterson J.W., Bö L., Mörk S., et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50 (2001) 389-400
40. Petzold A., Baker D., Pryce G., et al. Quantification of neurodegeneration by measurement of brain-specific proteins. J. Neuroimmunol. 138 (2003) 45-48
41. Prineas J.W., Barnard R.O., Revesz T., et al. Multiple sclerosis. Pathology of recurrent lesions. Brain 116 (1993) 681-693
42. Pryce G., O'Neill J.K., Croxford J.L., et al. Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis. J. Neuroimmunol. 165 (2005) 41-52
43. Raine C.S., and Wu E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 52 (1993) 199-204
44. Ramer L.M., Borisoff J.F., and Ramer M.S. Rho-kinase inhibition enhances axonal plasticity and attenuates cold hyperalgesia after dorsal rhizotomy. J. Neurosci. 24 (2004) 10796-10805
45. Ransohoff R.M., Hamilton T.A., Tani M., et al. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7 (1993) 592-600
46. Scott A.L., Borisoff J.F., and Ramer M.S. Deafferentation and neurotrophin-mediated intraspinal sprouting: a central role for the p75 neurotrophin receptor. Eur. J. Neurosci. 21 (2005) 81-92
47. Setzu A., Lathia J.D., Zhao C., et al. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54 (2006) 297-303
48. Sriram S., and Steiner I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann. Neurol. 58 (2005) 939-945
49. Swanborg R.H. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin. Immunol. Immunopathol. 77 (1995) 4-13
50. Tani M., Glabinski A.R., Tuohy V.K., et al. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 148 (1996) 889-896
51. Vercellino M., Plano F., Votta B., et al. Grey matter pathology in multiple sclerosis. J. Neuropathol. Exp. Neurol. 64 (2005) 1101-1107
52. Villarroya H., Klein C., Thillaye-Goldenberg B., et al. Distribution in ocular structures and optic pathways of immunocompetent and glial cells in an experimental allergic encephalomyelitis (EAE) relapsing model. J. Neurosci. Res. 63 (2001) 525-535
53. Willis W.D., and Coggeshall R.E. Sensory Mechanisms of the Spinal Cord (2004), Kluwer Academic/Plenum Publishers, New York
54. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18 (1998) 601-609
55. Wujek J.R., Bjartmar C., Richer E., et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J. Neuropathol. Exp. Neurol. 61 (2002) 23-32
56. Zhao C., Fancy S.P., Kotter M.R., et al. Mechanisms of CNS remyelination - the key to therapeutic advances. J. Neurol. Sci. 233 (2005) 87-91